A new analysis reveals that half of patients using weight loss drugs like Ozempic and Wegovy stop taking them within a year, raising concerns about the need for long-term use. The study, involving over 77,000 people, found that younger, poorer individuals are more likely to quit, often due to side effects or cost. Researchers emphasize the importance of supporting patients to improve adherence and health outcomes. Teljes cikk (Euronews.com)